s6y
Company name or ticker
Search
Cocrystal Pharma, Inc.
PRE 14A
Preliminary proxy statement not related to a contested matter or merger/acquisition
Filed
Friday, April 1, 2022
Period
Apr 1, 2022
Accession number
0001493152-22-008681
Documents
formpre14a.htm
PRE 14A
On sec.gov
Filing index
All files
Complete submission text
SGML header